The Future of Generic Drug Competition
December 9, 2019

On December 9, Axinn partner Chad Landmon participated in a webinar entitled, "The Future of Generic Drug Competition: Deconstructing FDA and Congressional Initiatives" hosted by FDAnews. 

This webinar addressed the various pathways to expedite approval of generic drug applications including the advantages and disadvantages of each method. Panelists also discussed what Congressional initiatives and measures are being proposed to spur generic drug competition. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.